<DOC>
	<DOCNO>NCT00001803</DOCNO>
	<brief_summary>The Von Hippel-Lindau ( VHL ) Disease Genetic Epidemiology Study family-based case-control study conduct National Cancer Institute . The study subject 603 individual determine belong family VHL disease confirm screen NIH protocol # 89-C-0086 1988 1998 . There 293 patient volunteer VHL disease 310 volunteer patient free VHL disease , already genetic test mutation VHL gene . Adults well child age 13 - 17 include . All subject give inform consent prior participation ; minor subject , assent obtain minor consent parent/guardian . This protocol provide potential benefit people VHL disease ( although necessarily study subject ) possibly people sporadic ( non-hereditary ) form tumor occur VHL disease . The risk discomfort associate study minor . The present protocol new epidemiologic component VHL research NIH relate expression VHL tumor lifestyle factor ( tobacco alcohol use ; physical activity ) , occupational exposure , reproductive hormonal factor , demographic factor , medication use , diet , putative susceptibility gene . Information collect telephone interview write , self-administered diet questionnaire . A cheek cell sample obtain analyse genetic polymorphism . Medical record obtain document event report subject interview . Primary comparison VHL patient particular manifestation VHL patient free condition . Additional comparison may make unaffected family member lack mutation VHL gene , appropriate .</brief_summary>
	<brief_title>Von Hippel-Lindau Disease Genetic Epidemiology Study</brief_title>
	<detailed_description>The Von Hippel-Lindau ( VHL ) Disease Genetic Epidemiology Study family-based case-control study conduct National Cancer Institute . The study subject 603 individual determine belong family VHL disease confirm screen NIH protocol # 89-C-0086 1988 1998 . There 293 patient volunteer VHL disease 310 volunteer patient free VHL disease , already genetic test mutation VHL gene . Adults well child age 13 - 17 include . All subject give inform consent prior participation ; minor subject , assent obtain minor consent parent/guardian . This protocol provide potential benefit people VHL disease ( although necessarily study subject ) possibly people sporadic ( non-hereditary ) form tumor occur VHL disease . The risk discomfort associate study minor . The present protocol new epidemiologic component VHL research NIH relate expression VHL tumor lifestyle factor ( tobacco alcohol use ; physical activity ) , occupational exposure , reproductive hormonal factor , demographic factor , medication use , diet , putative susceptibility gene . Information collect telephone interview write , self-administered diet questionnaire . A cheek cell sample obtain analyse genetic polymorphism . Medical record obtain document event report subject interview . Primary comparison VHL patient particular manifestation VHL patient free condition . Additional comparison may make unaffected family member lack mutation VHL gene , appropriate .</detailed_description>
	<mesh_term>Von Hippel-Lindau Disease</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Eligible patient volunteer : 1. enrol protocol 89C0086 ; 2. member family least one person diagnose VHL NIH ; 3. least 13 year age . Patient volunteer see protocol 89C0086 diagnosed VHL , risk VHL , unaffected eligible study . Additional family screen throughout field period meeting eligibility criterion also able participate .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 27, 2016</verification_date>
	<keyword>Gene-Environment Interaction</keyword>
	<keyword>Kidney Cancer</keyword>
	<keyword>VHL</keyword>
	<keyword>Genetic Epidemiology</keyword>
</DOC>